Its emergence has already led to travel restrictions, high-level government meetings and promises by vaccine makers to start working on strain-specific vaccines just in case.
But it has a long way to go to take over from Delta, the variant that dominates all over the world. And the long list of variants that at first frightened the world before falling off the map can be a reminder that viruses are unpredictable.
Here's a look at the named coronavirus variants.
WHO designates coronavirus variants as either variants of concern -- meaning they look dangerous enough to bear close scrutiny and continual updates -- or as variants of interest, or variants under monitoring. Only five currently meet the definition for variants of concern: Alpha, Beta, Gamma, Delta and Omicron.
The first sample of the Omicron or B.1.1.529 lineage was taken November 9, according to WHO. It got noticed because of a surge of cases in South Africa.
"This new variant, B.1.1.529 seems to spread very quick!" Tulio de Oliveira, director of South Africa's Center for Epidemic Response & Innovation, and a genetics researcher at Stellenbosch University, said on Twitter.
Also, genetic sequencing showed it carried a large number of troubling mutations on the spike protein -- the knoblike structure on the surface of the virus that it uses to grapple onto the cells it infects.
Some of those mutations were already recognized from other variants and were known to make them more dangerous, including one called E484K that can make the virus less recognizable to some antibodies -- immune system proteins that are a frontline defense against infection and that form the basis of monoclonal antibody treatments.
Like Delta, Omicron also carries a mutation called D614G, which appears to help the virus better attach to the cells it infects.
"The number of mutations per se does not mean that the new variant will cause any problems; although it may make it more likely to look different to the immune system," Dr. Peter English, former chair of the British Medical Association's Public Health Medicine Committee, said in a statement.
What worries scientists is the number of mutations affecting the spike protein. That's because most of the leading vaccines target the spike protein. Vaccines made by Pfizer/BioNTech, Moderna, Johnson & Johnson, AstraZeneca and other companies all use just small pieces or genetic sequences of the virus and not whole virus, and all of them use bits of the spike protein to elicit immunity. So a change in the spike protein that made it less recognizable to immune system proteins and cells stimulated by a vaccine would be a problem.
So far, there's no evidence this has happened but there is no way of knowing by looking at the mutations alone. Researchers will have to wait and see if more breakthrough infections are caused by Omicron than by other variants.
The other fear is that the mutations might help make the virus less susceptible to monoclonal antibody treatments. However, WHO says it's unlikely these mutations would affect other Covid-19 treatments, including antiviral drugs in development and the steroid dexamethasone.
It takes an extra layer of testing above and beyond standard tests to detect infection to tell which variant of coronavirus has infected someone. Genetic sequencing must be conducted and that takes longer than a quick antigen test or a PCR test.
It's also too soon to tell whether Omicron causes more severe disease, although one doctor who treated some patients in South Africa told Reuters her patients had only mild symptoms. "The most predominant clinical complaint is severe fatigue for one or two days, with then the headache and the body aches and pain," Dr. Angelique Coetzee, a private practitioner and chair of the South African Medical Association, said.
Those factors may influence the rise of the variant in South Africa as opposed to countries where more people are vaccinated and fewer have immunocompromising conditions.
Physical barriers also will work against any mutant virus. These include masks, handwashing, physical distancing and good ventilation. "Much uncertain but we know what works vs. CoV-19: - improving indoor ventilation - quality masks/respirators - avoid indoor crowds - distancing - test, isolate, quarantine - vax + booster now for Delta," Dr. Jeffrey Duchin, health officer for Seattle & King County, tweeted Sunday.
While experts say they're watching closely, several have said they are not especially worried about Omicron just yet.
"I don't think we should panic," Robert Garry, a professor of microbiology and immunology at Tulane University School of Medicine, told CNN.
"The sky is not falling," Dr. Peter Hotez, dean of the School of Tropical Medicine at Baylor, told CNN. "We've not seen any evidence that Omicron causes any more severe disease than any other variants."
The Delta variant of coronavirus is now the dominant lineage in the US and much of the world. The Delta variant accounts for 99.9% of cases in the US, according to the US Centers for Disease Control and Prevention.
Also known as B.1.617.2, it is clearly more transmissible than other variants, but it is still unclear if it causes more severe disease.
It quickly took over from the B.1.1.7, or Alpha, variant in most countries.
Delta also carries a cluster of mutations on the spike protein. It can also evade the immune system, which may mean people who have been infected once with an older variant may be more likely to catch it again. It also eludes the effects of a monoclonal antibody treatment called bamlanivimab, made by Eli Lilly and Company, but is vulnerable to the protection offered by other monoclonal antibody treatments.
First identified as a variant of concern last December, the B.1.1.7 or Alpha variant of coronavirus was worrying public health officials last spring. It swept across England quickly and then out into the world, quickly becoming the dominant lineage in the United States. It has now been demoted to "Variant Being Monitored" by the CDC because of its low impact in the US.
It was shown to be at least 50% more transmissible than older lineages. It carries 23 mutations, including one called N501Y that increases transmission.
It's fully susceptible to monoclonal antibody treatments and vaccines.
First seen in South Africa, the B.1.351 or Beta variant has both the E484K mutation that is linked with immune escape and the N501Y mutation suspected of helping make many other variants more contagious. It has been shown to be 50% more transmissible than older strains and evades Lilly's dual monoclonal antibody treatment, but not others.
Blood tests and real-life use both suggest it can infect people who have recovered from coronavirus and also people who have been vaccinated against Covid-19.
Vaccine makers trying to get out ahead of the new variants by developing booster shots had focused on B.1.351, as it's the variant scientists most fear could elude vaccine protection. But partial escape doesn't mean full escape, and vaccines are still expected to protect people to some degree.
It was overtaken by Delta in South Africa and have never gained much of a foothold in the US, despite the worry it caused, and is now designated a Variant Being Monitored by the CDC.
The P.1 or Gamma variant that swept Brazil also never gained much ground elsewhere and is also now a CDC Variant Being Monitored.
Gamma carries both the E484K and N501Y mutations, with more than 30 others. It has been demonstrated to evade the effects of Lilly's monoclonal antibody treatment but not one made by Regeneron. Blood tests show it might partly escape both natural and vaccine-elicited immune responses.
WHO Variants of Interest
Lambda: Lambda or C.37 was designated a WHO Variant of Interest in June. The CDC doesn't mention it.
Mu: Mu or B.1.621 caused a flurry of fear when it was declared a WHO Variant of Interest in August, but it soon fizzled out. It's now designated Variant Being Monitored by the CDC.
Variants Being Monitored by CDC
Epsilon: The B.1.427 and B.1.429 variants are usually lumped together and known as Epsilon. First seen in California, this one has the same L452R mutation carried by Delta, but not some of its other mutations and has not taken off in the way Delta has.
Iota: First seen in New York last November, the B.1.526 or Iota variant spread at first, accounting for as many as 9% of samples last April, but it's now virtually disappeared. It has what's called a 484 mutation that should help the virus attach more easily to the cells it infects and makes the virus less recognizable to the immune system.
Eta: First seen in the UK and Nigeria, Eta, also known as B.1.525, carries the E484K mutation. It has also virtually disappeared.
Zeta: Circulating in Brazil since last year, this variant, also known as P.2, also carries the E484K mutation and has not been found widely globally. It's almost disappeared in the US, according to the CDC.
There are no variants designated Nu or Xi. WHO decided "Nu" sounded too much like the English word "new" and Xi is a common last name.
Originally posted here:
Coronavirus variants: Here's what we know - CNN
- Is a universal coronavirus vaccine on the horizon? - National Geographic - January 19th, 2022
- Boris Johnson says Englands virus rules will ease next week. - The New York Times - January 19th, 2022
- Coronavirus Roundup: One Year of the Biden COVID-19 Response - GovExec.com - January 19th, 2022
- Thousands in Hong Kong volunteer to adopt hamsters amid COVID-19 fears - Reuters - January 19th, 2022
- Coronavirus spreading like never before in Americas, health agency says - Reuters Canada - January 19th, 2022
- Here are the latest COVID-19 numbers for Wednesday, January 19 - WNEP Scranton/Wilkes-Barre - January 19th, 2022
- How does COVID-19 misinformation compare with other health topics? - Medical News Today - January 19th, 2022
- 538 more coronavirus cases have been reported across Maine - Bangor Daily News - January 19th, 2022
- Is headache a symptom of the omicron COVID variant? - FOX31 Denver - January 19th, 2022
- Omicron won't be the last COVID-19 variant, WHO says - WXYZ - January 19th, 2022
- The cGAS-STING pathway drives type I IFN immunopathology in COVID-19 - Nature.com - January 19th, 2022
- Lesson of the Day: At-Home Coronavirus Tests Are Inaccessible to Blind People - The New York Times - January 19th, 2022
- With many wondering whether Omicron means we're approaching the endemic phase of Covid-19, Fauci cautions it's still too soon to tell - CNN - January 18th, 2022
- Study on 4th COVID vaccine dose shows effectiveness; results against omicron unclear - WXYZ - January 18th, 2022
- Coronavirus in Ohio Monday update: Over 19,500 new cases, 2.4 million total - NBC4 WCMH-TV - January 18th, 2022
- Preparing for the endemic stage of COVID-19: What this looks like - KOIN.com - January 18th, 2022
- White House to offer free COVID tests beginning Wednesday how to get them - KXAN.com - January 18th, 2022
- COVID tests, other public service events on MLK Day in L.A. - Los Angeles Times - January 18th, 2022
- Covid loses 90% of ability to infect within 20 minutes in air study - The Guardian - January 18th, 2022
- Federal at-home COVID-19 tests will be available this week - KRIS Corpus Christi News - January 18th, 2022
- One year later: What symptoms do some COVID-19 patients still have? - WKBW-TV - January 18th, 2022
- Novel coronavirus - Wikipedia - January 16th, 2022
- Virus Outbreak: Covid (Coronavirus) News and Analysis From Jan. 15 - Bloomberg - January 16th, 2022
- Corona Virus SalzburgerLand.com - January 16th, 2022
- Protest in Netherlands against coronavirus measures - Reuters - January 16th, 2022
- For Coronavirus Testing, the Nose May Not Always Be Best - The New York Times - January 16th, 2022
- 14 more Mainers have died and another 1,359 coronavirus cases reported across the state - Bangor Daily News - January 16th, 2022
- Encouraging signs plan B Covid measures may soon be lifted in England - The Guardian - January 16th, 2022
- Experts warn against using Benadryl and milk to treat COVID, despite NC lawmakers post - KXAN.com - January 16th, 2022
- What do we know about the 175,000 people who died of Covid in the UK? - The Guardian - January 16th, 2022
- Coronavirus Data for January 12, 2022 | mayormb - Executive Office of the Mayor - January 16th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 16th, 2022
- Brazil registers 48520 new cases of coronavirus and 175 deaths-health ministry - Reuters - January 16th, 2022
- 3 big Covid misconceptions people still have, according to infectious disease experts - CNBC - January 16th, 2022
- High demand for COVID testing calls Kauai War Memorial Convention Hall to action - KHON2 - January 16th, 2022
- The Covid Race to Watch: Vaccines vs. Variants - The Wall Street Journal - January 16th, 2022
- Hacking a home COVID test by adding a throat swab is a hot topic on Twitter : Goats and Soda - NPR - January 13th, 2022
- Coronavirus Data for January 11, 2022 | mayormb - Executive Office of the Mayor - January 13th, 2022
- Shawnee County Covid Indicator shows cases of coronavirus rising by more than 25% - KSNT News - January 13th, 2022
- Coronavirus in Ohio Thursday update: More than 19,000 new cases reported - NBC4 WCMH-TV - January 13th, 2022
- England cuts coronavirus isolation to 5 days - POLITICO Europe - January 13th, 2022
- COVID-19 in South Dakota: 2,584 total new cases; Death toll rises to 2,544; Active cases at 24,796 - KELOLAND.com - January 13th, 2022
- The Real Reason Americans Aren't Isolating - The Atlantic - January 13th, 2022
- China: Over 20 million in COVID-19 lockdown ahead of 2022 Olympics - NPR - January 13th, 2022
- Coronavirus in Arkansas: another record as over 10,000 new cases reported, 14 more deaths - KNWA - January 13th, 2022
- Utah surge ongoing with 12,990 new COVID-19 cases Thursday - fox13now.com - January 13th, 2022
- Increasing demand for coronavirus tests in Southern Oregon - KDRV - January 13th, 2022
- The Mood in the Capitol Was Already Dark. Then Came Omicron. - The New York Times - January 13th, 2022
- Information for travellers in regards to the corona virus ... - January 10th, 2022
- Corona Virus Update, Currently There Are 179 active ... - January 10th, 2022
- A Surge in Hospitalized Young Children Infected With the Coronavirus - The New York Times - January 10th, 2022
- Coronavirus in Ohio Sunday update: Just over 19,000 new cases and less than 100 new hospitalizations - WKBN.com - January 10th, 2022
- Coronavirus Briefing: A Pandemic of the Forgotten - The New York Times - January 10th, 2022
- COVID-19 surge has overwhelmed some Pa. hospitals and now their workers are getting sick, too - The Philadelphia Inquirer - January 10th, 2022
- Coronavirus: should the UK make vaccination mandatory? - The Guardian - January 10th, 2022
- COVID-19: UK records 141,472 new cases and further 97 coronavirus-related deaths - Sky News - January 10th, 2022
- Flu and Covid at the Same Time? Your 'Flurona' Questions, Answered - The New York Times - January 10th, 2022
- States are scrambling to keep up with an increase in Covid-19 hospitalizations and the demand for testing - CNN - January 10th, 2022
- Health experts want to focus on 'new normal' with the coronavirus | TheHill - The Hill - January 10th, 2022
- Chicago's COVID-19 fight with teachers hangs over a 2nd week - KMTV - 3 News Now - January 10th, 2022
- From delta to omicron, heres how scientists know which coronavirus variants are circulating in the US - KRQE News 13 - January 10th, 2022
- Coronavirus Watch: Oregon breaks COVID-19 case record for the third day running - KDRV - January 7th, 2022
- From delta to omicron, here's how scientists know which coronavirus variants are circulating in the US - The Conversation US - January 7th, 2022
- Understanding flurona: person has the flu and the coronavirus simultaneously - fox2now.com - January 7th, 2022
- Rapid nasal COVID tests feared to be returning false negatives - Axios - January 7th, 2022
- COVID infections hit another daily record in Louisiana as hospitalizations rise - The Advocate - January 7th, 2022
- Coronavirus Data for January 4, 2022 | mayormb - Executive Office of the Mayor - January 7th, 2022
- If you give yourself a COVID test, who tracks the results? - Los Angeles Times - January 7th, 2022
- How TV Shows Are Moving Past the Coronavirus Pandemic - The New York Times - January 7th, 2022
- COVID-19 testing in Massachusetts impacted due to snow - WWLP.com - January 7th, 2022
- Washington to expand access to coronavirus tests, to help contain spread of COVID-19 - KOMO News - January 7th, 2022
- Coronavirus Omicron variant, vaccine, and case numbers in the United States: Jan. 7, 2022 - Medical Economics - January 7th, 2022
- Coronavirus in Ohio Thursday update: Another day of more than 19,000 new cases - WKBN.com - January 7th, 2022
- COVID-19: Did Omicron evolve in mice? - Medical News Today - January 7th, 2022
- Hogan says 10 new hospital-based COVID testing sites to open in Maryland - WTOP - January 7th, 2022
- Outbreak hits Rhode Island hospital after COVID-positive staff called in to work - fox4kc.com - January 7th, 2022
- Swedens king and queen test positive for the coronavirus. - The New York Times - January 5th, 2022
- W.H.O. Downplays Threat From New Virus Variant in France - The New York Times - January 5th, 2022
- Omicron estimated to be 95.4% of coronavirus variants in U.S. - CDC - Reuters - January 5th, 2022
- US COVID cases are on the rise, but this doctor sees hope on the horizon : Coronavirus Updates - NPR - January 5th, 2022